Laurus Labs Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Laurus Labs Ltd. from all sources in a single place.

Load latest

Laurus Labs Ltd.

25 Jul 2025

893.95

-0.10%

Result

Laurus Labs Ltd - 540222 - Unaudited Financial Results For The Quarter Ended 30.06.2025

BSE India

Please see attached

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1580.00	1778.87	1197.42	-11.2%	32.0%
Operating Profit Qtr	382.13	420.60	171.20	-9.1%	123.2%
Net Profit Qtr	163.02	233.67	12.51	-30.2%	1203.1%
Earning Per Share Adjusted latest Qtr	3.02	4.33	0.23	-30.3%	1213.0%

* Consolidated data

Detailed Results

Laurus Labs Ltd.

17 Jul 2025, 11:46PM

893.95

-0.10%

Andhra okays 39,473 cr investment across 22 projects, 30k+ jobs ahead

Business Standard

The eighth State Investment Promotion Board of Andhra Pradesh headed by Chief Minister N Chandrababu Naidu on Thursday approved 22 projects worth Rs 39,473 crore with the scope to generate 30,899 jobs, the government said. The CM directed ministers and officials to create the relevant ecosystem around the industrial projects coming up in the state. "The eighth SIPB headed by CM Chandrababu approved investments worth Rs 39,473 crore. The 22 projects approved today will provide jobs to 30,899 people," an official release said. The approved projects included an investment of Rs 1,800 crore from Renew Vyoman Power Pvt Ltd in Kurnool and Nandyal districts, JSW Neo Energy (Rs 2,000 crore; Kadapa), JSW AP Steel Plant (Rs 4,500 crore; Kadapa) and Laurus Labs (Rs 5,630 crore; Anakapalli). Other projects included Lulu Shopping Malls International Ltd (Rs 1,222 crore; Vizag & Vijayawada), Renew Photovoltaic (Rs 3,700 crore; Anakapalli) and AS International (Rs 1,000 crore; Chittoor), among ..

Laurus Labs Ltd. has gained 31.41% in the last 3 Months

Laurus Labs Ltd.

10 Jul 2025

893.95

-0.10%

Company Update

Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please see annexed enclosure.

pdf

Laurus Labs Ltd.

09 Jul 2025

893.95

-0.10%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please see annexed enclosure.

pdf

Laurus Labs Ltd.

09 Jul 2025

893.95

-0.10%

Board Meeting

Laurus Labs Ltd - 540222 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve Please see annexed enclosure.

pdf

Laurus Labs Ltd.

09 Jul 2025

893.95

-0.10%

Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?

Business Standard

Donald Trump threatens of a potential 200% tariff on pharma imports; can this derail the rally in pharma shares, which have gained up to 50% in 3 months. Here's what the technical charts suggest.

Laurus Labs Ltd. has an average target of 686.25 from 4 brokers.

Laurus Labs Ltd.

01 Jul 2025

893.95

-0.10%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Please see annexed enclosure.

pdf

Laurus Labs Ltd.

30 Jun 2025

893.95

-0.10%

Laurus Labs nears record high after 4 years, zooms 84% from 52-week low

Business Standard

Laurus Labs management sees a clear pathway for further margin expansion as the company continue delivering on mid-late phase projects, ramping up new assets, and better asset utilisation.